HCSGD entry for FGF23
1. General information
Official gene symbol | FGF23 |
---|---|
Entrez ID | 8074 |
Gene full name | fibroblast growth factor 23 |
Other gene symbols | ADHR FGFN HPDR2 HYPF PHPTC |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0005105 | Type 1 fibroblast growth factor receptor binding | IEA | molecular_function |
GO:0005576 | Extracellular region | TAS | cellular_component |
GO:0005615 | Extracellular space | IDA ISS | cellular_component |
GO:0006796 | Phosphate-containing compound metabolic process | IEA | biological_process |
GO:0007173 | Epidermal growth factor receptor signaling pathway | TAS | biological_process |
GO:0008083 | Growth factor activity | IEA | molecular_function |
GO:0008286 | Insulin receptor signaling pathway | TAS | biological_process |
GO:0008543 | Fibroblast growth factor receptor signaling pathway | TAS | biological_process |
GO:0010966 | Regulation of phosphate transport | IDA | biological_process |
GO:0010980 | Positive regulation of vitamin D 24-hydroxylase activity | IDA | biological_process |
GO:0030154 | Cell differentiation | IEA | biological_process |
GO:0030502 | Negative regulation of bone mineralization | IDA | biological_process |
GO:0030643 | Cellular phosphate ion homeostasis | IEA | biological_process |
GO:0038095 | Fc-epsilon receptor signaling pathway | TAS | biological_process |
GO:0042369 | Vitamin D catabolic process | IDA | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045668 | Negative regulation of osteoblast differentiation | IDA | biological_process |
GO:0045893 | Positive regulation of transcription, DNA-templated | IEA | biological_process |
GO:0046888 | Negative regulation of hormone secretion | ISS | biological_process |
GO:0048011 | Neurotrophin TRK receptor signaling pathway | TAS | biological_process |
GO:0048015 | Phosphatidylinositol-mediated signaling | TAS | biological_process |
GO:0055062 | Phosphate ion homeostasis | IMP | biological_process |
GO:0070374 | Positive regulation of ERK1 and ERK2 cascade | IEA | biological_process |
GO:0090080 | Positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.4827649595 | 0.8978192774 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.0936940297 |
GSE13712_SHEAR | Down | -0.1211238406 |
GSE13712_STATIC | Up | 0.1058802737 |
GSE19018 | Down | -0.0948099305 |
GSE19899_A1 | Up | 0.1789720387 |
GSE19899_A2 | Up | 0.1278271703 |
PubMed_21979375_A1 | Down | -0.1265565671 |
PubMed_21979375_A2 | Up | 0.0889644584 |
GSE35957 | Down | -0.0101610490 |
GSE36640 | Up | 0.0069393066 |
GSE54402 | Up | 0.1604264755 |
GSE9593 | Down | -0.0603296047 |
GSE43922 | Up | 0.0276723034 |
GSE24585 | Up | 0.1160271894 |
GSE37065 | Up | 0.0099583595 |
GSE28863_A1 | Down | -0.1007629047 |
GSE28863_A2 | Up | 0.1032050231 |
GSE28863_A3 | Up | 0.3670084708 |
GSE28863_A4 | Down | -0.0194158503 |
GSE48662 | Up | 0.0113504106 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-335-5p | MIMAT0000765 | MIRT017013 | Microarray | Functional MTI (Weak) | 18185580 |
hsa-miR-26b-5p | MIMAT0000083 | MIRT029016 | Microarray | Functional MTI (Weak) | 19088304 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 7 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27125746 | Alpha-Klotho (alphaKlotho) protein is encoded by the gene, Klotho, and functions as a coreceptor for endocrine fibroblast growth factor-23 |
26797283 | Although muscle wasting and/or degeneration are prevalent in patients with chronic kidney disease, it remains unknown whether FGF-23 influences muscle homeostasis and regeneration |
26797283 | In this study we sought to investigate the effects of FGF-23 on MSCs isolated from human skeletal muscle in vitro |
26797283 | MSCs and satellite cells were treated with FGF-23 and angiotensin-II for 48 h |
26797283 | Treatment with FGF-23 significantly decreased the number of MSCs compared to controls, while treatment with angiotensin-II did not |
26797283 | FGF-23 and angiotensin-II both left the cell counts of the satellite cells unchanged |
26797283 | FGF-23 also significantly altered the gene expression of oxidative stress regulators in the cells |
26797283 | In conclusion, FGF-23 induced premature senescence in MSCs from skeletal muscle via the p53/p21/oxidative-stress pathway |
26797283 | The interaction between the MSCs and FGF-23 may play a key role in the impaired muscle reparative mechanisms of chronic kidney disease |
26528423 | Membrane Klotho forms a complex with fibroblast growth factor (FGF) receptors, functions as an obligatory co-receptor for FGF23, which is involved in aging and the development of chronic diseases via regulation of P i and vitamin D metabolism |
25511229 | However, serum levels of oxidative stress and inflammatory markers, serum fibroblast growth factor 23, and aortic calcium content in CKD-CaC rats were higher than those in CKD-LaC rats |
23666415 | FGF23 and Klotho in chronic kidney disease |
23666415 | PURPOSE OF REVIEW: The wealth of data regarding fibroblast growth factor-23 (FGF23) and Klotho in chronic kidney disease (CKD) has risen exponentially over the past decade |
23666415 | RECENT FINDINGS: The phosphaturic hormone FGF23 increases dramatically as renal function declines |
23666415 | Identification of contributing stimuli to the rise in FGF23 is fundamental and recent evidence suggest a multifactorial cause which entails perturbed osteocyte function and renal mechanisms such as Klotho deficiency and, somewhat paradoxically, systemic Klotho excess |
23666415 | Circulating FGF23 predicts adverse outcomes, particularly cardiovascular disease, in CKD as well as in the general population |
23666415 | The concept of FGF23 merely as a biomarker and regulator of mineral metabolism is currently challenged by data linking FGF23 to pathological processes such as cardiac hypertrophy |
23666415 | Conversely, tissue level of the FGF23 coreceptor Klotho declines in early CKD and this deficiency is linked to accelerated ageing, cellular senescence, vascular calcification, oxidative stress and renal fibrosis |
22242193 | 1,25-dihydroxyvitamin D3 (1,25D3) was reported to induce premature organismal aging in fibroblast growth factor-23 (Fgf23) and klotho deficient mice, which is of main interest as 1,25D3 supplementation of its precursor cholecalciferol is used in basic osteoporosis treatment |
21235497 | This review discusses the molecular mechanisms of cellular senescence and its affect on calcification of vascular cells, the relevance of phosphate regulation and the function of FGF23 and Klotho proteins |
Entries Per Page
Displaying Page of